Overture, founded by Martin Varsavsky, is developing robotic systems that fabricate embryos for use in fertility treatments. The company supplies clinics with the technical equipment without upfront equipment sales and instead charges on a per-cycle service basis. The project began roughly 18 months before July 2019 and aims to run test cases of robot-created embryos in late 2019. Overture planned to bring a final product to market in the fourth quarter of 2020. Santiago Munné is a cofounder who will lead embryology while Varsavsky leads the software and robotics technology efforts. The company is categorized in biotechnology/genetic engineering and is based in Madrid.

Total raised

$20M

Funding rounds

1

Latest round

Series A

Latest activity

Jul 2019